genedrive testing kit verified to work with Beckman Coulter extraction process
Initial testing took place using Beckman Coulter Life Sciences' chemistry on respiratory swabs in conjunction with gendrive’s 96 SARS-CoV-2 equipment
Sector
Health
988 stories · page 43 of 50
MindMed announces R&D collaboration with Liechti Lab in Switzerland on psilocybin
The pair will seek to better understand and compare the altered states of consciousness induced by psilocybin and LSD
Tiziana Life Sciences: HC Wainwright sees “meaningful upside” to price target if foralumab COVID-19 trial is a success
In its latest research, the US broker rates the shares a 'buy' and values them at U$11 each
Algernon Pharmaceuticals gets green light to continue its Phase 2b/3 coronavirus study from Data and Safety Monitoring Board
The drug repurposing firm said the DSMB had unanimously approved the continuation of the study
Humanigen and Lonza reveal collaboration to expand manufacturing COVID-19 therapeutic candidate lenzilumab
The collaboration ramps up lenzilumab manufacturing capacity ahead of anticipated Emergency Use Authorization for the drug in 2020
Humanigen says review of lenzilumab Phase 3 study of COVID-19 by data safety monitoring board gets green light to continue
After completing their analysis, the DSMB recommended that the trial continue according to the existing trial protocol without modification
MagicMed Industries closes oversubscribed private placement for over $1.64M with Mackie Research Capital Corporation
The funds will help expand MagicMed’s Psybrary, a molecular derivatives library designed to be a key platform for the psychedelics industry to develop new patented products
Revive Therapeutics set to collaborate with University of Wisconsin System on Psilocybin clinical trial
The trial is for the potential treatment of methamphetamine use disorder
Empower Clinics plans to acquire Kai Medical Laboratory to advance coronavirus national testing programs
Empower Clinics CEO Steven McAuley said Kai has a "newly built high-complexity lab offering a wide array of testing services, that together we will leverage to serve the massive demand" for COVID testing in the US
Champignon Brands to offer esketamine for depression at Ontario clinic
In May, Health Canada approved esketamine — an altered form of ketamine — for the treatment of major depressive disorder
Bone Therapeutics to complete recruitment for knee pain trial by year-end
Approximately 20%of the targeted assessable patients have been treated since the initiation of the trial.
Thoughtful Brands hails strong sales performance of its Nature's Exclusive brand in year to date
The e-commerce firm put the strong performance of the Nature's Exclusive brand down to the fact it has added innovative products and made "significant" investment in customer acquisition
MindMed announces first-ever clinical trial combining MDMA and LSD
The trial is scheduled to start in the fourth quarter at the University Hospital Basel's Liechti Lab in Switzerland
Empower Clinics sees 2Q revenue soar on the back of record patient growth
For the period ended June 30, 2020, the group clocked up revenue of $923,876 driven by 6,696 patient visits
Thoughtful Brands says its subsidiary Ecommerce Tech has acquired a key e-Commerce software platform
The group has finalized the deal with Unified Funding LLC’s wholly owned subsidiary Offer Space LLC to acquire the asset for US$1 million
Thoughtful Brands closes deal to acquire natural health companies Golden Path and Wild Mariposa
Golden Path and Wild Mariposa join a growing portfolio of names under the Thoughtful Brands umbrella, including Nature’s Exclusive in North America and Sativida in Spain and Mexico
Thoughtful Brands inks letters of intent to consider acquisition of Golden Path and Wild Mariposa
Both Golden Path and Wild Mariposa are direct-to-consumer eCommerce brands selling a range of natural health products, including nutraceutical and hemp-based CBD
Mota Ventures Corp. unveils name change to Thoughtful Brands Inc., expected to take place on August 14
The company said it believes that the name and symbol change better reflect the success of its strategic growth and its drive to acquire and develop branded products and research initiatives in the natural health products space
Binovi Technologies to bring its vision therapy technology platform to North American classrooms as it enters the K-12 education space
Students will use Binovi’s technology-driven vision training protocols to develop and strengthen literacy skills
Codebase Ventures completes final tranche of non-brokered private placement, raising proceeds of $135,000
The company said the net proceeds from the private placement will be used for general working capital and to fund future investments